Yuki Yamada

7PUBLICATIONS
30CO-AUTHORS
Predictive and prognostic markersObstetrics and gynaecologyCancer diagnosisCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Feb 19, 2025
Assessment of tissue factor pathway inhibitor 2 (TFPI2) as a novel serum marker for malignant tumors of the ovary before and after treatment: A case-control study.

Yuki Ogawara, Naho Ruiz Yokota, Yuki Yamada

|Oct 17, 2022
Successful vaginoscopic excision of the vaginal septum in a virgin girl of obstructed hemivagina and ipsilateral renal anomaly: Case report and review of literature.

Yuki Yamada, Ryuji Kawaguchi, Kana Iwai

|Jul 02, 2022
Tissue factor pathway inhibitor 2: A potential diagnostic marker for discriminating benign from malignant ovarian tumors.

Hiroshi Kobayashi, Yuki Yamada, Ryuji Kawaguchi

|Jun 04, 2021
Validation of magnetic resonance relaxometry R2 value and cyst fluid iron level for diagnosis of ovarian endometrioma.

Shogo Imanaka, Yuki Yamada, Naoki Kawahara

|Oct 03, 2019
Clinicopathologic features, treatment, prognosis and prognostic factors of neuroendocrine carcinoma of the endometrium: a retrospective analysis of 42 cases from the Kansai Clinical Oncology Group/Intergroup study in Japan.

Harunobu Matsumoto, Mototsugu Shimokawa, Kaei Nasu

|Jul 24, 2019
Preoperative plasma D-dimer level is a useful prognostic marker in ovarian cancer.

Yuki Yamada, Ryuji Kawaguchi, Kana Iwai

Pageof 2

Frequent Collaborators

3 joint publications

Fuminori Kimura

2 joint publications

Ryuji Kawaguchi

2 joint publications

Hiroshi Kobayashi

1 joint publications

Etsuko Miyagi